Rossmore Private Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-461
| Closed | -$292K | – | 262 |
|
|
2025
Q1 | $292K | Buy |
461
+1
| +0.2% | +$634 | 0.04% | 214 |
|
|
2024
Q4 | $328K | Hold |
460
| – | – | 0.04% | 199 |
|
|
2024
Q3 | $484K | Hold |
460
| – | – | 0.06% | 171 |
|
|
2024
Q2 | $483K | Hold |
460
| – | – | 0.06% | 168 |
|
|
2024
Q1 | $443K | Hold |
460
| – | – | 0.06% | 176 |
|
|
2023
Q4 | $404K | Hold |
460
| – | – | 0.06% | 179 |
|
|
2023
Q3 | $379K | Hold |
460
| – | – | 0.06% | 174 |
|
|
2023
Q2 | $331K | Hold |
460
| – | – | 0.05% | 188 |
|
|
2023
Q1 | $378K | Hold |
460
| – | – | 0.06% | 173 |
|
|
2022
Q4 | $332K | Hold |
460
| – | – | 0.05% | 182 |
|
|
2022
Q3 | $317K | Hold |
460
| – | – | 0.06% | 183 |
|
|
2022
Q2 | $272K | Sell |
460
-200
| -30% | -$118K | 0.05% | 193 |
|
|
2022
Q1 | $461K | Hold |
660
| – | – | 0.07% | 162 |
|
|
2021
Q4 | $417K | Hold |
660
| – | – | 0.07% | 172 |
|
|
2021
Q3 | $399K | Hold |
660
| – | – | 0.07% | 168 |
|
|
2021
Q2 | $369K | Hold |
660
| – | – | 0.06% | 173 |
|
|
2021
Q1 | $312K | Buy |
660
+200
| +43% | +$94.5K | 0.06% | 172 |
|
|
2020
Q4 | $222K | Hold |
460
| – | – | 0.05% | 189 |
|
|
2020
Q3 | $257K | Hold |
460
| – | – | 0.06% | 163 |
|
|
2020
Q2 | $287K | Hold |
460
| – | – | 0.08% | 147 |
|
|
2020
Q1 | $225K | Buy |
+460
| New | +$225K | 0.08% | 136 |
|